This policy reflects advice from professional bodies, such as the American College of Occupational and Environmental Medicine (ACOEM), which notes that the present availability of coverage for obesity care is piecemeal and calls for guidance on how to operationalize evidence-based behavioral, nutritional, pharmacological, and surgical obesity treatment modalities as health benefits. The ACOEM further notes that obesity represents an ongoing cost to employers and society at large in the form of current and future health care expenses, absenteeism, presenteeism, and workers compensation costs related to injuries and illnesses. OPMs 2025 Call Letter, issued January 15, 2025, identified this context of rising utilization and cost amidst inconsistent application of comprehensive, evidence-based care
Novo Nordisk and Eli Lilly control approximately 87% of prescription weight management drug revenue
Reporters noted Cohens transparency about being prescribed GLP-1 receptor agonists for both weight management and heart health, drawing attention from audiences facing similar health challenges
These compounds have been implicated in fatal and non-fatal overdoses
Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT)
Now that we are getting closer to the point of knowing about the treatment in Ahmedabad, one must understand about methods to use at home to whiten skin
